DPP4 and hyperlipidemia: Studies in cell cultures and animal models have demonstrated that DPP-4 inhibitors have trophic effects on pancreatic β-cells [17–19] and can improve other metabolic characteristics, such as hyperlipidemia and low-grade inflammation.